Also known as: MSK
BostonGene announced a strategic collaboration with Daiichi Sankyo to integrate AI-driven analytics into an ADC development program. The company also revealed six abstracts will be presented at the EHA 2026 Congress in Stockholm. The research showcases integrated multiomics and predictive modeling for blood cancer treatment optimization.
A multi-institutional study found that pairing an investigational immunotherapy with hormone therapy before surgery reduced regulatory T cells in prostate tumors and improved cancer-free outcomes in high-risk patients.
Zsofia K. Stadler, MD, has been appointed as the next Editor-in-Chief of JCO Precision Oncology, effective July 1, 2026. She is an Attending Physician and Clinic Director at Memorial Sloan Kettering Cancer Center.
Insilico Medicine and Memorial Sloan Kettering Cancer Center have entered a collaborative research agreement to discover new therapeutic targets for gastroesophageal malignancies using AI-powered platforms and extensive multi-omic clinical datasets.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07612046 |
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening |
RECRUITING | |
| NCT07594522 |
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer |
RECRUITING | PHASE1/PHASE2 |
| NCT07590804 |
A Dietary Study for People With Clonal Hematopoiesis |
RECRUITING | NA |
| NCT07587957 |
Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors |
RECRUITING | NA |
| NCT07575893 |
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma |
NOT_YET_RECRUITING | PHASE1 |
| NCT07566377 |
Cord Blood Transplantation in Children and Young Adults With Blood Cancer |
RECRUITING | PHASE2 |
| NCT07549477 |
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer |
RECRUITING | NA |
| NCT07548164 |
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer |
RECRUITING | PHASE3 |
| NCT07539441 |
A Study of Mirdametinib in People With Central Nervous System Tumors |
RECRUITING | PHASE1/PHASE2 |
| NCT07535463 |
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer |
RECRUITING | PHASE1/PHASE2 |
